MiR-4716-3p and the Target AKT2 Gene/rs2304186 SNP Are Associated with Blood Cancer Pathogenesis in Pakistani Population

Overview

Journal Noncoding RNA Res

Date 2024 Apr 5

PMID 38577021

Authors

Jairus Olumasai Nandwa

Azhar Mehmood

Ishrat Mahjabeen

Kayode Yomi Raheem

Mamoudou Hamadou

Mouhamed Z K A Raimi

Mahmood A Kayani

Affiliations

Soon will be listed here.

Abstract

AKT2 is crucial for cancer cells' invasion, metastasis, and survival. It is a possible downstream gene target of cancer glycolysis-related microRNAs. The study investigated the role of miRNA-4716-3p, rs2304186, and the AKT2 gene in blood cancer pathogenesis. RT-qPCR was used to analyze AKT2 gene mRNA and miRNA-4716-3p expression in 200 blood cancer samples and 200 healthy controls. Furthermore, Tetra-ARMS PCR was used to examine the rs2304186 AKT2 SNP in 300 patients and 290 control samples. miRNA-4716-3p was shown to be significantly downregulated (p = 0.0294), whereas mRNA expression of the AKT2 gene was found to be significantly upregulated (p = 0.0034) in blood cancer patients compared to healthy individuals. miRNA-4716-3p downregulation (p = 0.0466) was more pronounced, while AKT2 upregulation was non-significant (p = 0.1661) in untreated patients compared to chemotherapy-treated patients. Blood cancer risk was significantly associated with the rs2304186 GT genotype (p = 0.0432), TT genotype (p = 0.0502), and mutant allele (T) frequency (p = 0.0008). Polymorphism rs2304186 was associated with an increased risk of blood cancer in dominant (p = 0.0011), recessive (p = 0.0502), and additive (p = 0.0008) genetic models. The results suggested that the rs2304186 and the deregulated expression of miRNA-4716-3p and AKT2 gene at the mRNA level may significantly increase the incidence of blood cancer, particularly in the Pakistani population. Therefore, these may function as suitable biomarkers for blood cancer diagnosis and prognosis. Additional, larger-scale investigations may be required to affirm these results.

References

Navarro A, Diaz T, Cordeiro A, Diaz Beya M, Ferrer G, Fuster D . Epigenetic regulation of microRNA expression in Hodgkin lymphoma. Leuk Lymphoma. 2015; 56(9):2683-9. DOI: 10.3109/10428194.2014.995650. View

Liu T, Zhu J, Du W, Ning W, Zhang Y, Zeng Y . AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma. Respir Res. 2020; 21(1):227. PMC: 7466426. DOI: 10.1186/s12931-020-01491-0. View

Malik M, Rizwan I, Hussain A . Health Related Quality of Life among Blood Cancer Patients in Pakistan: A Cross Sectional Survey. Inquiry. 2021; 58:469580211025211. PMC: 8212374. DOI: 10.1177/00469580211025211. View

Miao L, Wang B, Zhang J, Yin L, Pu Y . A functional SNP in miR-625-5p binding site of AKT2 3'UTR is associated with noise-induced hearing loss susceptibility in the Chinese population. Environ Sci Pollut Res Int. 2021; 28(30):40782-40792. DOI: 10.1007/s11356-021-13649-4. View

Mendez-Ferrer S, Bonnet D, Steensma D, Hasserjian R, Ghobrial I, Gribben J . Bone marrow niches in haematological malignancies. Nat Rev Cancer. 2020; 20(5):285-298. PMC: 9912977. DOI: 10.1038/s41568-020-0245-2. View

Xu K, Li S, Whitehead T, Pandey P, Kang A, Morimoto L . Epigenetic Biomarkers of Prenatal Tobacco Smoke Exposure Are Associated with Gene Deletions in Childhood Acute Lymphoblastic Leukemia. Cancer Epidemiol Biomarkers Prev. 2021; 30(8):1517-1525. PMC: 8338876. DOI: 10.1158/1055-9965.EPI-21-0009. View

Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I . The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res. 2011; 71(17):5765-78. DOI: 10.1158/0008-5472.CAN-11-0368. View

Arshad F, Ali A, Rehman G, Ahsan Halim S, Waqas M, Khalid A . Comparative Expression Analysis of Breakpoint Cluster Region-Abelson Oncogene in Leukemia Patients. ACS Omega. 2023; 8(6):5975-5982. PMC: 9933183. DOI: 10.1021/acsomega.2c07885. View

Visone R, Veronese A, Rassenti L, Balatti V, Pearl D, Acunzo M . miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood. 2011; 118(11):3072-9. PMC: 3175784. DOI: 10.1182/blood-2011-01-333484. View

10.

Li J, Yang X, Guan H, Mizokami A, Keller E, Xu X . Exosome-derived microRNAs contribute to prostate cancer chemoresistance. Int J Oncol. 2016; 49(2):838-46. PMC: 6904112. DOI: 10.3892/ijo.2016.3560. View

11.

Saeed S, Khan J, Iqbal N, Irfan S, Shafique A, Awan S . Cancer and how the patients see it; prevalence and perception of risk factors: a cross-sectional survey from a tertiary care centre of Karachi, Pakistan. BMC Public Health. 2019; 19(1):360. PMC: 6444817. DOI: 10.1186/s12889-019-6667-7. View

12.

Li J, Mo S, Sun Y, Huang H, Wang S . Association between AKT2 gene polymorphism and polycystic ovary syndrome: a case-control study. Gynecol Endocrinol. 2021; 37(7):635-639. DOI: 10.1080/09513590.2021.1932800. View

13.

Bresin A, Callegari E, DAbundo L, Cattani C, Bassi C, Zagatti B . miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model. Oncotarget. 2015; 6(23):19807-18. PMC: 4637322. DOI: 10.18632/oncotarget.4415. View

14.

Rykova E, Ershov N, Damarov I, Merkulova T . SNPs in 3'UTR miRNA Target Sequences Associated with Individual Drug Susceptibility. Int J Mol Sci. 2022; 23(22). PMC: 9692299. DOI: 10.3390/ijms232213725. View

15.

Zakaria Z, Umi S, Mokhtar S, Mokhtar U, Zaiharina M, Aziz A . An alternate method for DNA and RNA extraction from clotted blood. Genet Mol Res. 2013; 12(1):302-11. DOI: 10.4238/2013.February.4.4. View

16.

Slattery M, Herrick J, Pellatt D, Mullany L, Stevens J, Wolff E . Site-specific associations between miRNA expression and survival in colorectal cancer cases. Oncotarget. 2016; 7(37):60193-60205. PMC: 5312378. DOI: 10.18632/oncotarget.11173. View

17.

Mahmood N, Shahid S, Bakhshi T, Riaz S, Ghufran H, Yaqoob M . Identification of significant risks in pediatric acute lymphoblastic leukemia (ALL) through machine learning (ML) approach. Med Biol Eng Comput. 2020; 58(11):2631-2640. DOI: 10.1007/s11517-020-02245-2. View

18.

Bustin S, Huggett J . qPCR primer design revisited. Biomol Detect Quantif. 2017; 14:19-28. PMC: 5702850. DOI: 10.1016/j.bdq.2017.11.001. View

19.

Mahlab-Aviv S, Boulos A, Peretz A, Eliyahu T, Carmel L, Sperling R . Small RNA sequences derived from pre-microRNAs in the supraspliceosome. Nucleic Acids Res. 2018; 46(20):11014-11029. PMC: 6237757. DOI: 10.1093/nar/gky791. View

20.

Zou M, Huang W, Wang X, Li J, Lv G, Wang B . Reduced expression of miRNA-1237-3p associated with poor survival of spinal chordoma patients. Eur Spine J. 2015; 24(8):1738-46. DOI: 10.1007/s00586-015-3927-9. View